JP2005179268A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005179268A5 JP2005179268A5 JP2003422472A JP2003422472A JP2005179268A5 JP 2005179268 A5 JP2005179268 A5 JP 2005179268A5 JP 2003422472 A JP2003422472 A JP 2003422472A JP 2003422472 A JP2003422472 A JP 2003422472A JP 2005179268 A5 JP2005179268 A5 JP 2005179268A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- peptide
- acid sequence
- specific amino
- tooth surface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000010647 peptide synthesis reaction Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 101000576810 Protobothrops flavoviridis Small serum protein 5 Proteins 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 101000704433 Streptococcus gordonii Agglutinin receptor Proteins 0.000 description 2
- 230000010065 bacterial adhesion Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003422472A JP2005179268A (ja) | 2003-12-19 | 2003-12-19 | 口腔用組成物 |
| AT04030053T ATE353912T1 (de) | 2003-12-19 | 2004-12-17 | Peptizusammensetzung für die mundhöhle |
| DE602004004754T DE602004004754T2 (de) | 2003-12-19 | 2004-12-17 | Peptidzusammensetzung für die Mundhöhle |
| EP04030053A EP1564218B1 (en) | 2003-12-19 | 2004-12-17 | Peptide composition for oral cavity |
| US11/013,430 US7094759B2 (en) | 2003-12-19 | 2004-12-17 | Oral modified SSP-5 antibacterial composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003422472A JP2005179268A (ja) | 2003-12-19 | 2003-12-19 | 口腔用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005179268A JP2005179268A (ja) | 2005-07-07 |
| JP2005179268A5 true JP2005179268A5 (enExample) | 2007-01-11 |
Family
ID=34697330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003422472A Pending JP2005179268A (ja) | 2003-12-19 | 2003-12-19 | 口腔用組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7094759B2 (enExample) |
| EP (1) | EP1564218B1 (enExample) |
| JP (1) | JP2005179268A (enExample) |
| AT (1) | ATE353912T1 (enExample) |
| DE (1) | DE602004004754T2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2477122C2 (ru) * | 2008-02-08 | 2013-03-10 | Колгейт-Палмолив Компани | Композиции и способы с применением пептидов, содержащих основные аминокислоты и протеазы |
| WO2013039861A2 (en) | 2011-09-12 | 2013-03-21 | modeRNA Therapeutics | Engineered nucleic acids and methods of use thereof |
| AU2013243949A1 (en) | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of biologics and proteins associated with human disease |
| DE18200782T1 (de) | 2012-04-02 | 2021-10-21 | Modernatx, Inc. | Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen |
| WO2017083515A2 (en) | 2015-11-10 | 2017-05-18 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
| KR102322170B1 (ko) * | 2016-02-26 | 2021-11-08 | (주)오케이바이오 | 치약조성물 |
| EP3571223B1 (en) | 2017-01-18 | 2024-09-18 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
| MX2021011355A (es) | 2019-03-18 | 2021-10-13 | Sunstar Americas Inc | Composicion para cuidado oral. |
| US11918675B2 (en) | 2019-12-16 | 2024-03-05 | Colgate-Palmolive Company | Oral care compositions |
| CN116710146A (zh) | 2020-04-03 | 2023-09-05 | 威特拉公司 | 抗体分子-药物偶联物及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816563A (en) * | 1983-11-25 | 1989-03-28 | Amtron, Inc. | Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof |
| ZA878295B (en) * | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
| CA2106609A1 (en) | 1992-09-28 | 1994-03-29 | Irene Yeatman Aldridge | Proteases to inhibit and remove biofilm |
| JP2002114709A (ja) | 2000-10-04 | 2002-04-16 | Univ Nihon | 虫歯予防剤 |
| JP2002284604A (ja) | 2001-03-29 | 2002-10-03 | Shiseido Co Ltd | 抗菌防黴助剤 |
| JP2002302404A (ja) | 2001-04-02 | 2002-10-18 | Shiseido Co Ltd | 抗菌防黴助剤 |
-
2003
- 2003-12-19 JP JP2003422472A patent/JP2005179268A/ja active Pending
-
2004
- 2004-12-17 AT AT04030053T patent/ATE353912T1/de not_active IP Right Cessation
- 2004-12-17 EP EP04030053A patent/EP1564218B1/en not_active Expired - Lifetime
- 2004-12-17 US US11/013,430 patent/US7094759B2/en not_active Expired - Lifetime
- 2004-12-17 DE DE602004004754T patent/DE602004004754T2/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003515323A5 (enExample) | ||
| JP2004501162A5 (enExample) | ||
| MXPA04008077A (es) | Anticuerpos ant-a° y su uso. | |
| JP2005179268A5 (enExample) | ||
| JP2005538719A5 (enExample) | ||
| WO2003025121A3 (en) | Igf-binding protein-derived peptide or small molecule | |
| JP2003525623A5 (enExample) | ||
| JP2004532624A5 (enExample) | ||
| JP2002540769A5 (enExample) | ||
| JP2006503088A5 (enExample) | ||
| JP2004508843A5 (enExample) | ||
| WO2001027136A3 (fr) | Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire | |
| WO2001053347A3 (fr) | Gene nphs2 implique dans le syndrome nephrotique cortico-resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques | |
| JP2005005118A5 (enExample) | ||
| JP2003245242A5 (enExample) | ||
| JP2005535281A5 (enExample) | ||
| WO2006075253A3 (en) | Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides. | |
| WO2003054009A3 (de) | Apoptotisch wirksame peptide | |
| JP2009532334A5 (enExample) | ||
| JP2002539794A5 (enExample) | ||
| JP2004526429A5 (enExample) | ||
| WO2002070557A3 (en) | Nuclear hormone receptor ligand binding domain | |
| JP2004527206A5 (enExample) | ||
| WO2002033058A3 (en) | Novel cysteine proteases and uses thereof | |
| HK1043155A1 (zh) | 噬菌體t4基因35的基因及蛋白質排列 |